Long-Term Immunogenicity after One and Two Doses of a Monovalent MF59-Adjuvanted A/H1N1 Influenza Virus Vaccine Coadministered with the Seasonal 2009-2010 Nonadjuvanted Influenza Virus Vaccine in HIV-Infected Children, Adolescents, and Young Adults in a Randomized Controlled Trial

Few data are available on the safety and long-term immunogenicity of A/H1N1 pandemic influenza vaccines for HIV-infected pediatric patients. We performed a randomized controlled trial to evaluate the safety and long-term immunogenicity of 1 versus 2 doses of the 2009 monovalent pandemic influenza A/...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Viganò, Alessandra, Giacomet, Vania, Pariani, Elena, Giani, Elisa, Manfredini, Valeria, Bedogni, Giorgio, Erba, Paola, Amendola, Antonella, Zanetti, Alessandro, Zuccotti, Gianvincenzo
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2011
Teme:
Vaccine Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165232/
https://ncbi.nlm.nih.gov/pubmed/21795458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.05200-11
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items